BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND GATA2, NFE1B, 2624, ENSG00000179348, MGC2306, P23769 AND Diagnosis
20 results:

  • 1. Identification of potential biomarkers for aging diagnosis of mesenchymal stem cells derived from the aged donors.
    Hao M; Jiang H; Zhao Y; Li C; Jiang J
    Stem Cell Res Ther; 2024 Mar; 15(1):87. PubMed ID: 38520027
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
    Cuccuini W; Collonge-Rame MA; Auger N; Douet-Guilbert N; Coster L; Lafage-Pochitaloff M
    Curr Res Transl Med; 2023; 71(4):103423. PubMed ID: 38016422
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Diagnostic work-up of hematological malignancies with underlying germline predisposition disorders (GPD).
    Kanagal-Shamanna R; Schafernak KT; Calvo KR
    Semin Diagn Pathol; 2023 Nov; 40(6):443-456. PubMed ID: 37977953
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The impact of surgical resection margins on outcomes for adults with head and neck osteosarcomas: A Canadian sarcoma research and Clinical Collaboration (CanSaRCC) study.
    Tzelnick S; Soroka HP; Tasnim N; Gilbert RW; Irish JC; Goldstein DP; Brown D; Gullane P; Chepeha DB; Yao CMKL; Sahovaler A; Witterick IJ; Monteiro E; Davies J; Huang SH; O'Sullivan B; Hahn E; Hosni A; Razak AA; Gupta AA; de Almeida JR
    Oral Oncol; 2023 Oct; 145():106495. PubMed ID: 37478572
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. How I diagnose myeloid neoplasms with germline predisposition.
    Patel N; Calvo KR
    Am J Clin Pathol; 2023 Oct; 160(4):352-364. PubMed ID: 37458302
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study.
    Baranwal A; Chhetri R; Yeung D; Clark M; Shah S; Litzow MR; Hogan WJ; Mangaonkar A; Alkhateeb HB; Singhal D; Cibich A; Bardy P; Kok CH; Hiwase DK; Shah MV
    Bone Marrow Transplant; 2023 Jul; 58(7):769-776. PubMed ID: 37012415
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
    Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
    Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. gata2 Deficiency in Adult Life Is Characterized by Phenotypic Diversity and Delayed diagnosis.
    Shamriz O; Zahalka N; Simon AJ; Lev A; Barel O; Mor N; Tal Y; Segel MJ; Somech R; Yonath H; Toker O
    Front Immunol; 2022; 13():886117. PubMed ID: 35603181
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ASXL1 and STAG2 are common mutations in gata2 deficiency patients with bone marrow disease and myelodysplastic syndrome.
    West RR; Calvo KR; Embree LJ; Wang W; Tuschong LM; Bauer TR; Tillo D; Lack J; Droll S; Hsu AP; Holland SM; Hickstein DD
    Blood Adv; 2022 Feb; 6(3):793-807. PubMed ID: 34529785
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Therapeutic options for CTLA-4 insufficiency.
    Egg D; Rump IC; Mitsuiki N; Rojas-Restrepo J; Maccari ME; Schwab C; Gabrysch A; Warnatz K; Goldacker S; Patiño V; Wolff D; Okada S; Hayakawa S; Shikama Y; Kanda K; Imai K; Sotomatsu M; Kuwashima M; Kamiya T; Morio T; Matsumoto K; Mori T; Yoshimoto Y; Dybedal I; Kanariou M; Kucuk ZY; Chapdelaine H; Petruzelkova L; Lorenz HM; Sullivan KE; Heimall J; Moutschen M; Litzman J; Recher M; Albert MH; Hauck F; Seneviratne S; Pachlopnik Schmid J; Kolios A; Unglik G; Klemann C; Snapper S; Giulino-Roth L; Svaton M; Platt CD; Hambleton S; Neth O; Gosse G; Reinsch S; Holzinger D; Kim YJ; Bakhtiar S; Atschekzei F; Schmidt R; Sogkas G; Chandrakasan S; Rae W; Derfalvi B; Marquart HV; Ozen A; Kiykim A; Karakoc-Aydiner E; Králíčková P; de Bree G; Kiritsi D; Seidel MG; Kobbe R; Dantzer J; Alsina L; Armangue T; Lougaris V; Agyeman P; Nyström S; Buchbinder D; Arkwright PD; Grimbacher B
    J Allergy Clin Immunol; 2022 Feb; 149(2):736-746. PubMed ID: 34111452
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pulmonary Manifestations of gata2 Deficiency.
    Marciano BE; Olivier KN; Folio LR; Zerbe CS; Hsu AP; Freeman AF; Filie AC; Spinner MA; Sanchez LA; Lovell JP; Parta M; Cuellar-Rodriguez JM; Hickstein DD; Holland SM
    Chest; 2021 Oct; 160(4):1350-1359. PubMed ID: 34089740
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Inherited gata2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance.
    Oleaga-Quintas C; de Oliveira-Júnior EB; Rosain J; Rapaport F; Deswarte C; Guérin A; Sajjath SM; Zhou YJ; Marot S; Lozano C; Branco L; Fernández-Hidalgo N; Lew DB; Brunel AS; Thomas C; Launay E; Arias AA; Cuffel A; Monjo VC; Neehus AL; Marques L; Roynard M; Moncada-Vélez M; Gerçeker B; Colobran R; Vigué MG; Lopez-Herrera G; Berron-Ruiz L; Méndez NHS; O'Farrill Romanillos P; Le Voyer T; Puel A; Bellanné-Chantelot C; Ramirez KA; Lorenzo-Diaz L; Alejo NR; de Diego RP; Condino-Neto A; Mellouli F; Rodriguez-Gallego C; Witte T; Restrepo JF; Jobim M; Boisson-Dupuis S; Jeziorski E; Fieschi C; Vogt G; Donadieu J; Pasquet M; Vasconcelos J; Ardeniz FO; Martínez-Gallo M; Campos RA; Jobim LF; Martínez-Barricarte R; Liu K; Cobat A; Abel L; Casanova JL; Bustamante J
    J Clin Immunol; 2021 Apr; 41(3):639-657. PubMed ID: 33417088
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Secondary acquisition of BCR-ABL1 fusion in de novo gata2-MECOM positive acute myeloid leukemia with subsequent emergence of a rare KMT2A-ASXL2 fusion.
    Blackburn PR; Huang L; Dalovisio A; Pitel BA; Chen D; Oliveira JL; Wood AJ; Smadbeck JB; Johnson SH; Vasmatzis G; Haferlach C; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Peterson JF
    Cancer Genet; 2020 Feb; 241():67-71. PubMed ID: 31902694
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Acquired and germline predisposition to bone marrow failure: Diagnostic features and clinical implications.
    Kallen ME; Dulau-Florea A; Wang W; Calvo KR
    Semin Hematol; 2019 Jan; 56(1):69-82. PubMed ID: 30573048
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Old and new tools in the clinical diagnosis of inherited bone marrow failure syndromes.
    West AH; Churpek JE
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):79-87. PubMed ID: 29222240
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Influence of Histologic Subtype in Predicting Survival of Lung cancer Patients With Spinal Metastases.
    Kumar N; Tan KA; Tan JH; Zaw AS; Hey HWD; Ruiz J; Stone E
    Clin Spine Surg; 2018 Feb; 31(1):E1-E7. PubMed ID: 27875414
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
    DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity.
    Zhang MY; Keel SB; Walsh T; Lee MK; Gulsuner S; Watts AC; Pritchard CC; Salipante SJ; Jeng MR; Hofmann I; Williams DA; Fleming MD; Abkowitz JL; King MC; Shimamura A
    Haematologica; 2015 Jan; 100(1):42-8. PubMed ID: 25239263
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Massively parallel sequencing reveals an accumulation of de novo mutations and an activating mutation of LPAR1 in a patient with metastatic neuroblastoma.
    Wei JS; Johansson P; Chen L; Song YK; Tolman C; Li S; Hurd L; Patidar R; Wen X; Badgett TC; Cheuk AT; Marshall JC; Steeg PS; Vaqué Díez JP; Yu Y; Gutkind JS; Khan J
    PLoS One; 2013; 8(10):e77731. PubMed ID: 24147068
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Heritable gata2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia.
    Hahn CN; Chong CE; Carmichael CL; Wilkins EJ; Brautigan PJ; Li XC; Babic M; Lin M; Carmagnac A; Lee YK; Kok CH; Gagliardi L; Friend KL; Ekert PG; Butcher CM; Brown AL; Lewis ID; To LB; Timms AE; Storek J; Moore S; Altree M; Escher R; Bardy PG; Suthers GK; D'Andrea RJ; Horwitz MS; Scott HS
    Nat Genet; 2011 Sep; 43(10):1012-7. PubMed ID: 21892162
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.